Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States

Sanjay Sethi,1 Antony Wright,2 Elisabeth Sophia Hartgers-Gubbels,3 Marlene Hechtner,3 Brendan Clark,4 Ciara Wright,2 Sue Langham,2 Roland Buhl5 1Pulmonary/Critical Care/Sleep Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA; 2Maverex Ltd., Newcastle Upon Tyne, NE6 2HL, UK; 3Boehringer Ingelheim GmbH, Ingelheim Am Rhein, Germany; 4Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 5Pulmonary Department, Mainz University Hospital, Mainz, GermanyCorrespondence: Antony Wright, Maverex Ltd, Newcastle Upon Tyne, NE6 2HL, UK, Tel +44 (0) 161 4646838, Email... Mehr ...

Verfasser: Sethi,Sanjay
Wright,Antony
Hartgers-Gubbels,Elisabeth Sophia
Hechtner,Marlene
Clark,Brendan
Wright,Ciara
Langham,Sue
Buhl,Roland
Dokumenttyp: Original Research
Erscheinungsdatum: 2022
Verlag/Hrsg.: Dove Press
Schlagwörter: International Journal of Chronic Obstructive Pulmonary Disease
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28946269
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://www.dovepress.com/costs-and-clinical-consequences-of-compliance-with-copd-gold-recommend-peer-reviewed-fulltext-article-COPD